World's Best Scientists 2026 revealed!
Stephen J. Clarke

Stephen J. Clarke

D-Index & Metrics

Medicine

D-Index
87
Citations
34618
World Ranking
13487
National Ranking
443

Stephen J. Clarke publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Stephen J. Clarke sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 486 publications — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Stephen J. Clarke D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Stephen J. Clarke sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 87 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Stephen J. Clarke is affiliated with the University of Sydney in Australia. Their research primarily spans the field of Medicine, with a focus on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery, and Epidemiology.

The scientist's work covers several main topics, including:

  • Lung Cancer Treatments and Mutations
  • Cancer Genomics and Diagnostics
  • Pancreatic and Hepatic Oncology Research
  • Lung Cancer Research Studies
  • Neuroendocrine Tumor Research Advances
  • Cancer Immunotherapy and Biomarkers
  • Colorectal Cancer Treatments and Studies

Frequent publication venues for their research include:

  • Journal of Clinical Oncology
  • PLoS ONE
  • Frontiers in Oncology
  • Lung Cancer
  • Cancers

Notable recent papers by Stephen J. Clarke include:

  • Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study (2023), published in Journal of Clinical Oncology
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer (2022), published in Nature Medicine
  • Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial (2020), published in Annals of Oncology
  • First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors (2023), published in Cancer Immunology Immunotherapy
  • Australian recommendations for the management of hepatocellular carcinoma: a consensus statement (2020), published in The Medical Journal of Australia

Throughout their career, Clarke has collaborated frequently with other researchers, including:

  • Nick Pavlakis
  • Malinda Itchins
  • Connie I. Diakos
  • Anthony J. Gill
  • David Chan

Best Publications

  • Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

    Leonard B. Saltz;Stephen Clarke;Eduardo Díaz-Rubio;Werner Scheithauer

  • Cancer-related inflammation and treatment effectiveness

    Connie I Diakos;Kellie A Charles;Donald C McMillan;Stephen J Clarke

  • The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer

    Graeme J.K. Guthrie;Kellie A. Charles;Campbell S.D. Roxburgh;Paul G. Horgan

  • Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer

    Jim Cassidy;Stephen Clarke;Eduardo Díaz-Rubio;Werner Scheithauer

  • Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial

    Aimery de Gramont;Eric Van Cutsem;Hans Joachim Schmoll;Josep Tabernero

  • Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study

    Nico van Zandwijk;Nick Pavlakis;Steven C Kao;Anthony Linton

  • Clinical Pharmacokinetics of Docetaxel

    Stephen J. Clarke;Laurent P. Rivory

  • Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer

    W Chua;K A Charles;V E Baracos;S J Clarke;S J Clarke

  • A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer.

    M J Proctor;D C McMillan;D S Morrison;C D Fletcher

  • Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial

    Bob T. Li;Ronglai Shen;Darren Buonocore;Zachary T. Olah

  • Regulation of Drug Metabolizing Enzymes and Transporters in Infection, Inflammation, and Cancer

    Edward T. Morgan;Kerry B. Goralski;Micheline Piquette-Miller;Kenneth W. Renton

  • First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

    Harpreet S Wasan;Peter Gibbs;Navesh K Sharma;Julien Taieb

  • High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy

    Steven C.H. Kao;Nick Pavlakis;Rozelle Harvie;Janette L. Vardy

  • Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: A systematic review

    E. Davis;B. Oh;P. Butow;Barbara Mullan

  • Impact of Medical Qigong on quality of life, fatigue, mood and inflammation in cancer patients: a randomized controlled trial

    B. Oh;B. Oh;P. Butow;Barbara Mullan;S. Clarke

  • XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results

    J Cassidy;S Clarke;E Díaz-Rubio;W Scheithauer

  • The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer.

    Joseph C. Y. Chan;David L. Chan;Connie I. Diakos;Alexander Engel

  • Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy

    Kellie A Slaviero;Stephen J Clarke;Laurent P Rivory

  • Inflammation and cancer: causes and consequences.

    M M Moore;W Chua;K A Charles;S J Clarke

  • Potential Regional Differences for the Tolerability Profiles of Fluoropyrimidines

    Daniel G. Haller;Jim Cassidy;Stephen J. Clarke;David Cunningham

Frequent Co-Authors

Anthony J. Gill
Anthony J. Gill University of Sydney
Michael Boyer
Michael Boyer University of Utah
Andrew J. McLachlan
Andrew J. McLachlan University of Sydney
Phyllis Butow
Phyllis Butow University of Sydney
John R. Zalcberg
John R. Zalcberg Monash University
David Goldstein
David Goldstein University of New South Wales
Michael J. Solomon
Michael J. Solomon Royal Prince Alfred Hospital
Paul Mitchell
Paul Mitchell University of Sydney
Christopher Liddle
Christopher Liddle University of Sydney
Gregory R. Pond
Gregory R. Pond McMaster University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA opens the door to various related degrees and career pathways that can be explored online. Many students consider nursing schools that don't require teas or hesi for admission, making entry into nursing programs more accessible for those seeking a flexible and straightforward nursing education.

For those interested in the administrative side of healthcare, enrolling in a healthcare administration degree online accredited can provide essential management skills and career advancement opportunities within hospitals, clinics, or public health organizations.

Registered nurses interested in advancing their clinical practice can take advantage of rn to np programs online, which enable them to bridge educational gaps and become nurse practitioners through flexible and efficient pathways.

Another growing field is nutrition. Earning an online degree in nutrition opens up opportunities in dietetics, wellness coaching, and public health nutrition, responding to the increasing demand for qualified nutrition professionals.

Exploring these alternative pathways can complement or provide a valuable alternative to traditional medical studies, offering flexibility and diverse roles within the healthcare sector.

Best Scientists Citing Stephen J. Clarke

Trending Scientists

Recently Published Articles